GEINO-11: A prospective multicenter, open label, phase II pilot clinical trial to evaluate safety and efficacy of Dacomitinib, a pan-HER irreversibl...

Date 27 September 2015
Event European Cancer Congress 2015
Session Central Nervous System
Topics Central Nervous System Malignancies
Presenter Sepúlveda, J.M.